Evidence map›Paper›PMID 38499577›Full record

ArticleNPJ Regenerative medicine2024

Multichannel bridges and NSC synergize to enhance axon regeneration, myelination, synaptic reconnection, and recovery after SCI.

Usha Nekanti, Pooja S Sakthivel, Atena Zahedi, Dana A Creasman, Rebecca A Nishi, Courtney M Dumont, Katja M Piltti, Glenn L Guardamondo, Norbert Hernandez, Xingyuan Chen and 13 more

Open access · goldAbstract read
In one paragraph

Article in NPJ Regenerative medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Nanoparticle and epothilone D combinatorial intervention improves motor performance and regeneration in chronic cervical spinal cord injury.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2025
    Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

23 authors at 5 institutions in 2 countries.

Usha NekantiSue and Bill Gross Stem Cell Research Center, University of California, Irvine, CA, USA. unekanti@uci.edu.ORCID http://orcid.org/0000-0002-6080-7135
Pooja S Sakthivel *Sue and Bill Gross Stem Cell Research Center, University of California, Irvine, CA, USA.
Atena Zahedi *Sue and Bill Gross Stem Cell Research Center, University of California, Irvine, CA, USA.
Dana A CreasmanSue and Bill Gross Stem Cell Research Center, University of California, Irvine, CA, USA.
Rebecca A NishiSue and Bill Gross Stem Cell Research Center, University of California, Irvine, CA, USA.ORCID http://orcid.org/0000-0001-9508-6668
Courtney M DumontDepartment of Biomedical Engineering, University of Michigan, Ann Arbor, MI, USA.
Katja M PilttiSue and Bill Gross Stem Cell Research Center, University of California, Irvine, CA, USA.ORCID http://orcid.org/0000-0002-9773-0442
Glenn L GuardamondoSue and Bill Gross Stem Cell Research Center, University of California, Irvine, CA, USA.
Norbert HernandezSue and Bill Gross Stem Cell Research Center, University of California, Irvine, CA, USA.
Xingyuan ChenSue and Bill Gross Stem Cell Research Center, University of California, Irvine, CA, USA.
Hui SongSue and Bill Gross Stem Cell Research Center, University of California, Irvine, CA, USA.
Xiaoxiao LinDepartment of Anatomy and Neurobiology, University of California, Irvine, CA, USA.
Joshua MartinezSue and Bill Gross Stem Cell Research Center, University of California, Irvine, CA, USA.
Lillian OnSue and Bill Gross Stem Cell Research Center, University of California, Irvine, CA, USA.
Anita LakatosSue and Bill Gross Stem Cell Research Center, University of California, Irvine, CA, USA.
Kiran PawarDepartment of Medicine, University of British Columbia, Vancouver, BC, Canada.ORCID http://orcid.org/0000-0001-7475-6570
Brian T DavidDepartment of Neurosurgery, Rush University Medical Center, Chicago, IL, USA.
Zhiling GuoDepartment of Medicine & Susan Samueli Integrative Health Institute, University of California, Irvine, CA, USA.
Stephanie K SeidlitsDepartment of Biomedical Engineering, The University of Texas at Austin, Austin, TX, USA.
Xiangmin XuDepartment of Anatomy and Neurobiology, University of California, Irvine, CA, USA.
Lonnie D SheaDepartment of Biomedical Engineering, University of Michigan, Ann Arbor, MI, USA.ORCID http://orcid.org/0000-0002-9296-9673
Brian J CummingsSue and Bill Gross Stem Cell Research Center, University of California, Irvine, CA, USA.ORCID http://orcid.org/0000-0003-3628-5290
Aileen J AndersonSue and Bill Gross Stem Cell Research Center, University of California, Irvine, CA, USA. aja@uci.edu.
University of California, Irvine · USUniversity of Michigan · USRush University Medical Center · USThe University of Texas at Austin · USUniversity of British Columbia · CA

Funding

University of California Health Participation in the National COVID Cohort Collaborative (N3C)UL1TR001414 · NCATS · UNIVERSITY OF CALIFORNIA-IRVINE · PI COOPER, DAN M, VILAIN, ERIC J. · 2015 to 2023
$35.1M
ResourceP40OD010996 · OD · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI STRICK, PETER · 2012 to 2024
$11.0M
Controlled Release Scaffolds for Nerve RegenerationR01EB005678 · NIBIB · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ANDERSON, AILEEN J, SHEA, LONNIE D · 2007 to 2018
$6.0M
Multi-channeled Bridges for Promoting Chronic Spinal Cord RepairR01NS117103 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ANDERSON, AILEEN J, CUMMINGS, BRIAN JOHN · 2020 to 2024
$2.1M
Engineered AAV vectors for combinatorial treatment of rare genetic brain diseasesR01FD007478 · FDA · UNIVERSITY OF CALIFORNIA-IRVINE · PI KIMONIS, VIRGINIA EUNICE, LA SPADA, ALBERT R · 2021 to 2023
$1.8M
FDA HHS R01 FD007478NCATS NIH HHS UL1 TR001414NIBIB NIH HHS R01 EB005678NIH HHS P40 OD010996NINDS NIH HHS R01 NS117103
6 · The paper itself

Abstract

Regeneration in the injured spinal cord is limited by physical and chemical barriers. Acute implantation of a multichannel poly(lactide-co-glycolide) (PLG) bridge mechanically stabilizes the injury, modulates inflammation, and provides a permissive environment for rapid cellularization and robust axonal regrowth through this otherwise inhibitory milieu. However, without additional intervention, regenerated axons remain largely unmyelinated (<10%), limiting functional repair. While transplanted human neural stem cells (hNSC) myelinate axons after spinal cord injury (SCI), hNSC fate is highly influenced by the SCI inflammatory microenvironment, also limiting functional repair. Accordingly, we investigated the combination of PLG scaffold bridges with hNSC to improve histological and functional outcome after SCI. In vitro, hNSC culture on a PLG scaffold increased oligodendroglial lineage selection after inflammatory challenge. In vivo, acute PLG bridge implantation followed by chronic hNSC transplantation demonstrated a robust capacity of donor human cells to migrate into PLG bridge channels along regenerating axons and integrate into the host spinal cord as myelinating oligodendrocytes and synaptically integrated neurons. Axons that regenerated through the PLG bridge formed synaptic circuits that connected the ipsilateral forelimb muscle to contralateral motor cortex. hNSC transplantation significantly enhanced the total number of regenerating and myelinated axons identified within the PLG bridge. Finally, the combination of acute bridge implantation and hNSC transplantation exhibited robust improvement in locomotor recovery. These data identify a successful strategy to enhance neurorepair through a temporally layered approach using acute bridge implantation and chronic cell transplantation to spare tissue, promote regeneration, and maximize the function of new axonal connections.

Identifiers

PMID38499577
PMCPMC10948859
OpenAlexW4392928534

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.